E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPANCA0007(Anticancer peptide)
DFBP ID DFBPANCA0007
Peptide sequence FKCRRWQWRMKKLGAPSITCVRRAF
Type Native peptide
Peptide/Function name Anticancer peptide, Lactoferricin B (LfcinB)
Function-activity relationship
Main bioactivity Anticancer activity
Otheir bioactivity Antimicrobial activity [D1], Immunomodulatory activity [D2], Multifunctional activity [D3]
Calculated physicochemical properties
Three-letter amino acid Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys-Val-Arg-Arg-Ala-Phe
Single-letter amino acid FKCRRWQWRMKKLGAPSITCVRRAF
Peptide length 25
Peptide mass
Experimental mass Theoretical mass
N.D 3125.80 Da c
Net charge 0.00 c
Isoelectric point (pI) 12.34 c
IC50 N.D
pIC50 N.D
GRAVY -0.5760 c
Hydrophilic residue ratio 48% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine milk
Precursor protein Lactoferricin (LfcinB) peptide from bovine lactoferrin
Residue position N.D
Precursor protein(s) search
Link-research
Link 1: DFBPANCA0055----Bovine milk----Lactoferrin (LF-B)
Link 2: DFBPANCA0334----Bovine milk protein----Lactoferricin
Biological/Functional activity & target protein
Anticancer activity
  1. Exhibited cytotoxic activity due to mitochondria (Jurkat T leukemia cells.).

  2. Disulfide bond is not required for the antimicrobial potency. Active against: Gram+ & Gram-, virus, fungi, cancer cells [2].

Specific target protein(s) N.D
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CS)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCC(=O)N[C@@]([H])(C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CS)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)O
Preparation method
Mode of preparation Enzymatic hydrolysis
Enzyme(s)/starter culture

Hydrolysis with pepsin.

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
DFBP
[D1] DFBPAMIC0005
[D2] DFBPIMMU0026
[D3] DFBPMUFU0698
BIOPEP-UWM [D4] 3229, 7051, 8175
APD [D5] -
BioPepDB [D6] -
MBPDB [D7] -
Reference(s)
Primary literature Mader JS, Salsman J, Conrad DM, Hoskin DW. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther. 2005 Apr;4(4):612-24.
PMID: 15827335
Other literature(s)

[1] Chalamaiah M, Yu W, Wu J. Immunomodulatory and anticancer protein hydrolysates (peptides) from food proteins: A review.[J]. Food Chemistry, 2018, 245:205-222.
[2] Peter M. Hwang,‡, Ning Zhou,‡, Xi Shan,§, et al. Three-Dimensional Solution Structure of Lactoferricin B, an Antimicrobial Peptide Derived from Bovine Lactoferrin†[J]. Biochemistry, 1998, 37(12):4288.
[3] Mader J S, Richardson A, Salsman J, et al. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria[J]. Experimental Cell Research, 2007, 313(12):2634-2650.

PubDate 2005
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214